Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionEmpowered Funds, LLC
Latest Disclosed Ownership195,463 shares
Latest Disclosed Value $ 27,241,678
Empowered Funds, LLC ownership in GILD / Gilead Sciences, Inc.

On May 15, 2026 - Empowered Funds, LLC filed a 13F-HR form disclosing ownership of 195,463 shares of Gilead Sciences, Inc. (CH:GILD) valued at $27,241,678 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 137,873 shares of Gilead Sciences, Inc.. This represents a change in shares of 41.77% during the quarter.

Empowered Funds, LLC has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options. The firm currently holds call options representing 5,151 of underlying shares valued at $442,214 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 195,463 57,590 41.77 27,242 60.98 0.0762
2026-02-11 2025-12-31 13F GILEAD SCIENCES COM 375558103 137,873 -11,878 -7.93 16,923 1.80 0.1347
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 149,751 -70,378 -31.97 16,622 -31.89 0.1678
2025-08-11 2025-06-30 13F GILEAD SCIENCES COM 375558103 220,129 625 0.28 24,406 -0.77 0.2762
2025-05-16 2025-03-31 13F GILEAD SCIENCES COM 375558103 219,504 -75 -0.03 24,595 21.27 0.3500
2025-01-28 2024-12-31 13F GILEAD SCIENCES COM 375558103 219,579 78,657 55.82 20,283 71.68 0.2965
2024-11-06 2024-09-30 13F GILEAD SCIENCES COM 375558103 140,922 -103,596 -42.37 11,815 -29.58 0.1858
2024-07-30 2024-06-30 13F GILEAD SCIENCES COM 375558103 244,518 48,792 24.93 16,776 17.02 0.2903
2024-05-07 2024-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 195,726 75,463 62.75 14,337 47.16 0.2589
2024-05-06 2024-03-31 13F GILEAD SCIENCES COM 375558103 195,726 75,463 14,337 0.1238
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 120,263 47,982 66.38 9,743 79.87 0.2446
2023-11-01 2023-09-30 13F GILEAD SCIENCES COM 375558103 72,281 45,916 174.16 5,417 166.67 0.1597
2023-07-27 2023-06-30 13F GILEAD SCIENCES COM 375558103 26,365 -15,518 -37.05 2,032 -41.55 0.0714
2023-04-05 2023-03-31 13F GILEAD SCIENCES COM 375558103 41,883 36,732 713.10 3,475 686.20 0.2049
2023-02-21 2022-12-31 13F/A-1 GLACIER BANCORP INC CALL 375558103 5,151 5,151 442 0.0289
2023-01-26 2022-12-31 13F GLACIER BANCORP INC CALL 375558103 5,151 5,151 0 0.0289
2022-04-21 2022-03-31 13F GILEAD SCIENCES COM 375558103 0 -66,876 -100.00 0 -100.00
2022-02-10 2021-12-31 13F GILEAD SCIENCES COM 375558103 66,876 66,876 4,856 0.5476
2021-02-02 2020-12-31 13F GILEAD SCIENCES COM 375558103 0 -44,117 -100.00 0 -100.00
2020-10-26 2020-09-30 13F GILEAD SCIENCES COM 375558103 44,117 9,396 27.06 2,788 4.38 0.8703
2020-07-16 2020-06-30 13F GILEAD SCIENCES COM 375558103 34,721 -3,147 -8.31 2,671 8.53 1.0340
2020-07-16 2020-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 37,868 0 0.00 2,461 0.00 0.8908
2020-04-16 2020-03-31 13F GILEAD SCIENCES COM 375558103 27,982 -9,886 2,092 1,206,619.1017
2020-07-16 2019-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 37,868 4,119 12.20 2,461 15.05 0.8908
2020-01-27 2019-12-31 13F GILEAD SCIENCES COM 375558103 37,868 4,119 2,461 1,008,288.3680
2019-11-01 2019-09-30 13F GILEAD SCIENCES COM 375558103 33,749 100 0.30 2,139 -5.90 0.9311
2019-07-09 2019-06-30 13F GILEAD SCIENCES COM 375558103 33,649 -5,737 -14.57 2,273 -11.21 0.9500
2019-05-10 2019-03-31 13F GILEAD SCIENCES COM 375558103 39,386 5,360 15.75 2,560 20.30 0.9152
2019-01-22 2018-12-31 13F GILEAD SCIENCES COM 375558103 34,026 -9,146 -21.19 2,128 -35.63 0.9004
2018-10-18 2018-09-30 13F GILEAD SCIENCES COM 375558103 43,172 -448 -1.03 3,306 7.76 0.9787
2018-07-09 2018-06-30 13F GILEAD SCIENCES COM 375558103 43,620 2,558 6.23 3,068 -0.10 0.9679
2018-04-25 2018-03-31 13F GILEAD SCIENCES COM 375558103 41,062 10,163 32.89 3,071 38.71 1.1211
2018-07-09 2017-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 30,899 9,377 43.57 2,214 26.95 1.1107
2018-07-09 2017-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 21,522 -3,763 -14.88 1,744 -2.57 1.1317
2018-07-09 2017-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 25,285 2,788 12.39 1,790 17.15 1.4515
2018-07-09 2017-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 22,497 22,497 1,528 1.5658
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-02-21 2022-12-31 13F/A GLACIER BANCORP INC CALL 5,151 442 n/a n/a n/a
2023-01-26 2022-12-31 13F GLACIER BANCORP INC CALL 5,151 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.